Role of the C domain of IGFs in synergistic promotion, with a substance P-derived peptide, of rabbit corneal epithelial wound healing

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 4, 2004, Pages 1125-1131

  Yamada, Naoyuki ^a   Yanai, Ryoji ^a   Nakamura, Masatsugu ^a,b   Inui, Makoto ^a   Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EYE DROPS; PROINSULIN; SERINE; SOMATOMEDIN B; SOMATOMEDIN C; SUBSTANCE P; OLIGOPEPTIDE; ONCOPROTEIN; PEPTIDE FRAGMENT; PHENYLALANYL GLYCYL LEUCYL METHIONINAMIDE; PHENYLALANYL-GLYCYL-LEUCYL-METHIONINAMIDE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MUTATION; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN DOMAIN; RABBIT; WOUND HEALING; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; IMMUNOBLOTTING; METABOLISM; ORGAN CULTURE TECHNIQUE; PROTEIN TERTIARY STRUCTURE;

AGED; ANIMALS; CELL MOVEMENT; DRUG SYNERGISM; EPITHELIUM, CORNEAL; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; OLIGOPEPTIDES; OPHTHALMIC SOLUTIONS; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; WOUND HEALING;

EID: 2142815152     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0626     Document Type: Article

References (34)

1. Clark RAF. Wound repair. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York: Plenum; 1998:3-50.
2. Nishida T, Nakagawa S, Awata T, et al. Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J Cell Biol. 1983;97:1653-1657.
3. Watanabe K, Nakagawa S, Nishida T. Stimulatory effects of fibronectin and EGF on migration of corneal epithelial cells. Invest Ophthalmol Vis Sci. 1987;28:205-211.
4. Nishida T, Nakamura M, Mishima H, Otori T. Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism. J Cell Physiol. 1992;153:1-5.
5. Nishida T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol. 1993;4:4-13.
6. Nishida T, Tanaka T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol. 1996;7:2-11.
7. Nakamura M, Nishida T. Synergistic effects of hyaluronan and fibronectin on epithelial migration in rabbit cornea in vitro. Cornea. 1999;18:686-692.
8. Nishida T, Nakagawa S, Nishibayashi C, Tanaka H, Manabe R. Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo. Arch Ophthalmol. 1984;102:455-456.
9. Nishida T, Nakamura M, Mishima H, Otori T, Hikida M. Interleukin 6 facilitates corneal epithelial wound closure in vivo. Arch Ophthalmol. 1992;110:1292-1294.
10. Nishida T, Nakagawa S, Awata T, Tani Y, Manabe R. Fibronectin eye drops for traumatic recurrent corneal lesion. Lancet 1983;2(8348):521-522.
11. Nishida T, Ohashi Y, Awata T, Manabe R. Fibronectin: a new therapy for corneal trophic ulcer. Arch Ophthalmol. 1983;101:1046-1048.
12. Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol. 1996;169:159-166.
13. Nakamura M, Ofuji K, Chikama T, Nishida T. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res. 1997;16:275-278.
14. Nakamura M, Ofuji K, Chikama T, Nishida T. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1. Br J Pharmacol. 1997;120:547-552.
15. 2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea. Br J Pharmacol. 1999;127:489-497.
16. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet. 1998;351:1783-1784.
17. Morishige N, Komatsubara T, Chikama T, Nishida T. Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy. Lancet. 1999;354:1613-1614.
18. Brown SM, Lamberts DW, Reid TW, Nishida T, Murphy CJ. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol. 1997;115:926-927.
19. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev. 1996;76:1005-1026.
20. Van den Brande JL. Structure of the human insulin-like growth factors. In: Schofield PN, ed. The Insulin-Like Growth Factors. New York: Oxford University Press; 1992:12-44.
21. Massague J, Czech MP. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982;257:5038-5045.
22. Zhang W, Gustafson TA, Rutter WJ, Johnson JD. Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity. J Biol Chem. 1994;269:10609-10613.
23. Bayne ML, Applebaum J, Underwood D, et al. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor. J Biol Chem. 1989;264:11004-11008.
24. Bayne ML, Applebaum J, Chicchi GG, Miller RE, Cascieri MA. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J Biol Chem. 1990;265:15648-15652.
25. Nakamura M, Chikama TI, Nishida T. Characterization of insulin-like growth factor-1 receptors in rabbit corneal epithelial cells. Exp Eye Res. 2000;70:199-204.
26. Nilsson B, Forsberg G, Hartmanis M. Expression and purification of recombinant insulin-like growth factors from Escherichia coli. Methods Enzymol. 1991;198:3-16.
27. Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13. Invest Ophthalmol Vis Sci. 2000;41:1448-1453.
28. Nakamura M, Nishida T, Ofuji K, et al. Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Exp Eye Res. 1997;65:321-329.
29. Cintron C, Hassenger L, Kublin CL, Friend J. A simple method for the removal of rabbit corneal epithelium utilizing n-heptanol. Ophthalmic Res. 1979;11:90-96.
30. Yanai R, Yamada N, Kugimiya N, Inui M, Nishida T. Mitogenic and antiapoptotic effects of various growth factors on human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:2122-2126.
31. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev. 1995;16:3-34.
32. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13:2905-2927.
33. Lee CH, Whiteman AL, Murphy CJ, et al. Substance P, insulinlike growth factor 1, and surface healing. Arch Ophthalmol. 2002;120:215-217.
34. Soloway MR, Stjemschantz J, Sears M. The miotic effect of substance P on the isolated rabbit iris. Invest Ophthalmol Vis Sci. 1981;20:47-52.